Report: New Israeli Biotech Fund To Raise $50-100M

November 16, 2015 | The Israel Biotech Fund, a new fund founded by Dr. Yuval Cabilly will receive investment of $50-100 million from Nasdaq-traded biomedical company Biogen, and Cabilly’s father, Dr. Shmuel Cabilly, a renowned oncologist and research scientist. According to Globes, the fund is intended to focus on Israeli biotech companies, an area of investment in which the Cabillys already have considerable experience.